|
Market Closed -
Nasdaq
00:00:00 05/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 4.310 USD | -4.86% |
|
-5.69% | -85.63% |
| 08-10 | Ernexa Therapeutics Announces Appointment of David Polinsky to Board of Directors | CI |
| 08-07 | Tranche Update on Ernexa Therapeutics Inc.'s Equity Buyback Plan announced on November 25, 2024. | CI |
| Market Cap | 7.04M 6.05M 5.7M 5.2M 9.73M 664M 9.76M 67.31M 26.12M 341M 26.42M 25.84M 1.1B | P/E 2026 * |
-0.24x | P/E 2027 * | -2.32x |
|---|---|---|---|---|---|
| Enterprise Value | 7.04M 6.05M 5.7M 5.2M 9.73M 664M 9.76M 67.31M 26.12M 341M 26.42M 25.84M 1.1B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
70.18% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ERNA | Delayed | |
CBOE
| ERNA | Real-time |
| 1 day | -4.86% | ||
| 1 week | -5.69% | ||
| Current month | -5.69% | ||
| 1 month | +5.12% | ||
| 3 months | -45.37% | ||
| 6 months | -43.84% | ||
| Current year | -85.63% |
| 1 week | 4.21 |  | 4.83 |
| 1 month | 4.02 | | 5.51 |
| Current year | 3.18 | | 35 |
| 1 year | 3.18 | | 71.5 |
| 3 years | 3.18 | | 984.37 |
| 5 years | 3.18 | | 102,224.95 |
| 10 years | 3.18 | | 605,024.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sanjeev Luther
CEO | Chief Executive Officer | 64 | 01/01/2024 |
Mark Keeley
DFI | Director of Finance/CFO | 63 | 10/08/2026 |
Robert Pierce
CTO | Chief Tech/Sci/R&D Officer | 61 | - |
| Director | Title | Age | Since |
|---|---|---|---|
William Wexler
BRD | Director/Board Member | 67 | 07/06/2022 |
James Bristol
CHM | Chairman | 79 | 19/12/2023 |
Sanjeev Luther
BRD | Director/Board Member | 64 | 01/01/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 31/08/26 | Free | Director | 5,944 | 0.5096% | ||
| 31/08/26 | Free | Director | 5,943 | 0.5095% | ||
| 31/08/26 | Free | Director | 5,083 | 0.4358% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.86% | -5.69% | -86.26% | -99.50% | 7.04M | |
| -2.54% | -2.84% | -1.77% | +14.72% | 48.93B | |
| -0.40% | +1.03% | +418.57% | +523.39% | 45.01B | |
| -1.42% | +2.30% | +42.67% | +21.22% | 44.07B | |
| -1.22% | -2.31% | +4.82% | +74.90% | 40.73B | |
| +0.53% | -1.36% | +16.87% | +47.12% | 33.52B | |
| -0.21% | +9.14% | - | - | 17.77B | |
| -0.35% | -1.56% | +21.42% | +123.04% | 16.5B | |
| -1.01% | +0.50% | +13.91% | +31.45% | 14.67B | |
| -1.65% | -1.03% | +75.93% | +41.22% | 13.77B | |
| Average | -1.31% | +0.05% | +56.24% | +86.40% | 27.5B | |
| Weighted average by Cap. | -1.03% | +0.11% | +89.42% | +127.92% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -19.98M -17.19M -16.17M -14.77M -27.64M -1.89B -27.71M -191M -74.16M -968M -75.01M -73.37M -3.12B | -21M -18.07M -17M -15.53M -29.05M -1.98B -29.13M -201M -77.96M -1.02B -78.85M -77.13M -3.28B |
| Net Debt | - | - |
Employees
6
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | $4.310 | -4.86% | 47,568 |
| 03/09/26 | $4.530 | -0.22% | 14,673 |
| 02/09/26 | $4.540 | +4.37% | 23,297 |
| 01/09/26 | $4.350 | -4.81% | 29,517 |
| 31/08/26 | $4.570 | 0.00% | 9,638 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.310USD
Average target price
30.00USD
Spread / Average Target
+596.06%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ERNA Stock
Select your edition
All financial news and data tailored to specific country editions
